The researchers of the Ri.MED Foundation, in close collaboration with clinical partners, are engaged in the simulation of physiological systems, studying biomaterials and engineered tissues, and developing new therapeutic solutions. Our Bioengineering and Tissue Engineering platforms are equipped with facilities enabling the synthesis and characterization of biomaterials and scaffolds for tissue engineering applications, and the design, development and preclinical validation of novel medical devices.

In 2020, the “BIOMITRAL” project by Antonio D’Amore, group leader in Tissue Engineering at Ri.MED Foundation, was awarded the ERC Consolidator Grant of the European Commission , and the Foundation was elected as host institution for the development of project that will be launched in 2021. New approaches are being studied for the characterization of biological tissues and biomaterials, and scaffold fabrication.

Important developments were accomplished in preclinical evaluation, in vitro and in vivo, of innovative cardiovascular solutions including engineered heart patches and new heart valves made using biostable polymers, engineered tissues and genetic engineering applications.

The possibility of in-house development and validation of clinical solutions, and the collaborations with the clinical centers, will facilitate the introduction of these new treatments in clinic.